"Calif[f], 70, is a well-regarded cardiologist and researcher who takes the helm at the FDA for a second time 13 months after it last had a permanent leader."
Category: Uncategorized
FDA Issues New DSCSA Guidances
To help our stakeholders understand these requirements, the FDA is issuing guidance documents intended to assist trading partners in complying with the law and achieving a safer, more secure and more trusted drug supply chain.
The Six Questions Every L&D Professional Should Ask Stakeholders To Identify Business Needs – eLearning Industry
FDA CGMP Online Training – trusted GMP online training courses offered by SkillsPlus International Inc. According to the article, there are 6 questions to ask: What is the training need? (What has driven this request?) What are the desired outcomes? (What does success look like?) Who is the target audience? What should they (the target […]
Medical Device Tax Is History After Trump Signs Repeal – BioFlorida
FDA GMP QSR cGMP Training Courses by SkillsPlus International Inc. According to the article: “The medical device industry hailed President Trump’s signing into law a bipartisan federal spending package that brings in an end to a tax the medical technology industry has been fighting against for the last decade. The 2.3% tax on medical device […]
FDA Reveals How Manufacturing Facilities are Prioritized for Inspections | RAPS
“The Site Selection Model (SSM), used by CDER staff to prioritize manufacturing sites for routine quality-related inspections, considers risk related to drug (drug substance and finished product) quality as may arise from violations of the CGMP requirements in the Food Drug & Cosmetic Act (FD&C Act). The SSM will use risk factors consistent with section […]